Nr 546 week 8 2024 - Study guides, Class notes & Summaries

NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+. Drug Name and Class FDA Indication (include stages ) Neurotransmitters Affected/Mechanism of Action Target Symptoms Short-acting, intermediate-acting, or long-acting. Duration of Action and Half-life (T1/2), CYP 450 enzyme Notable Side Effects/Precautions /Patient Education Instructions Donepezil (Aricept) Alzheimer’s disease – mild, moderate, and severe Acetylcholine enzyme inhibitor Reversibly but noncompeti...

NR 546 Week 8 Assignment; Neurotransmitter Table 2023/2024 | 100% Correct Verified

NR 546 / NR546 Neurotransmitter Table * To be completed throughout course and submitted in Week 8* 2023/2024

Midterm Exam: NR546/ NR 546 (Latest Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Guide |Weeks 1-4 Covered| Questions and Verified Answers| 100% Correct- Chamberlain Q: FGA side effects hyperprolactinemia, extrapyramidal symptom (EPS), QT pro- longation, tornadoes de pointes, blood dyscrasias, sedation, orthostatic hypoten- sion, dizziness. Q: Clozapine Answer: not indicated for use in acute presentation of schizophrenia, ab- solute n...

NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+. Drug Name and Class FDA Indication (include stages ) Neurotransmitters Affected/Mechanism of Action Target Symptoms Short-acting, intermediate-acting, or long-acting. Duration of Action and Half-life (T1/2), CYP 450 enzyme Notable Side Effects/Precautions /Patient Education Instructions Donepezil (Aricept) Alzheimer’s disease – mild, moderate, and severe Acetylcholine enzyme inhibitor Reversibly but noncompeti...

NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+. Drug Name and Class FDA Indication (include stages ) Neurotransmitters Affected/Mechanism of Action Target Symptoms Short-acting, intermediate-acting, or long-acting. Duration of Action and Half-life (T1/2), CYP 450 enzyme Notable Side Effects/Precautions /Patient Education Instructions Donepezil (Aricept) Alzheimer’s disease – mild, moderate, and severe Acetylcholine enzyme inhibitor Reversibly but noncompeti...

NR 546 Week 8 Course Reflection 2023/2024 | 100% Correct Verified NR 546 Week 8 Course Reflection 2023/2024 | 100% Correct Verified

NR 546 Week 2, 3, 8 Assignment; Neurotransmitter Table - Merged Together (2023/2024) | 100% Correct Verified

week 8 NR 546 Exam 2024/2025 Questions With Completed & Verified Solution.